BeiGene (BGNE)
(Delayed Data from NSDQ)
$198.50 USD
+0.34 (0.17%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $198.56 +0.06 (0.03%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Brokerage Reports
0 items in cart
BeiGene, Ltd. [BGNE]
Reports for Purchase
Showing records 1 - 12 ( 12 total )
Company: BeiGene, Ltd.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for BGNE 112123
Provider: Stock Traders Daily
Analyst: Research Department
Company: BeiGene, Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended July 7
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: BeiGene, Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended March 11.
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: BeiGene, Ltd.
Industry: Medical - Biomedical and Genetics
Company: BeiGene, Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended September 11
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: BeiGene, Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended May 15
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: BeiGene, Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended May 8
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: BeiGene, Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended May 1
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: BeiGene, Ltd.
Industry: Medical - Biomedical and Genetics
Time to Bring the B (Cell) Team into the COVID Wars
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: BeiGene, Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended March 13
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: BeiGene, Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Retail Sales Tracker for Hem. Malignancies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: BeiGene, Ltd.
Industry: Medical - Biomedical and Genetics
Weekly Retail Sales Tracker for Hem. Malignancies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
|